An average of more than 20 clinical research studies, involving hundreds of patients, are ongoing in the Department of Nephrology and Hypertension, at all times. Studies are generated through institutional/department funding, NIH and other Federal sources, corporate sources and individual donations. Many are international, multicenter trials, lasting from a few months to several years.
Some areas of study include:
- Phase II-IV investigational hypertensive drug studies, with special interest in diabetic nephropathy, IgA nephropathy and hypertension complicated by cardiovascular conditions.
- End-stage renal disease morbidity and mortality with multiple studies specific to the dialysis population, such as homocysteine control, levocarnitine and exercise tolerance, and infection and access issues.
- Utilizing its unique resources, the Department also collaborates with other sub-specialities, for example, endocrinology, cardiology, urology and vascular medicine in many research capacities.
Patents may be referred from CCF physicians, affiliate staff, outside physicians or self-referred. For further information, you may contact our research manager at 216.444.0124.
